In the ever-evolving landscape of drug discovery and development, the era of easily attainable breakthroughs appears to have passed. The low-hanging fruit has largely been picked, and novel challenges now confront the industry. Despite these challenges, there remains a substantial unmet need.
Several interconnected trends, some long-established, are shaping the quest for novel drugs. These include miniaturization, automation, high-throughput screening, enhanced information retrieval from assays, relevance, and artificial intelligence. Automation, especially, has become an indispensable ally in drug discovery and is the focus of this eBook. It has streamlined many workflows, allowing for higher efficiency, reproducibility, and precision in experiments.
Topics covered in this eBook include
- Trends driving change in discovery workflows
- Automation for nucleic acid automation
- A modular, benchtop liquid handling platform to automate the most time-consuming protocols
- A new tool to expedite in silico drug discovery
Complete the adjacent form for immediate access to this essential resource.